Impact of Shared Treatment Decision Making Between Physicians and Patients on Treatment Satisfaction in Hypertension

Author(s)

Yaoki Sonohara, MS, Ryosuke Nishi, MS, Sooyeol Lim, MBA, MSc, Michael LoPresti, MSc.
Value and Access Department, INTAGE Healthcare Inc., Tokyo, Japan.
OBJECTIVES: Hypertension is a common chronic disease in Japan, and managing blood pressure with medication is important for preventing adverse cardiovascular events. Treatment satisfaction is known to influence medication adherence and real-world treatment effectiveness. Recently, shared decision-making between physicians and patients has been shown to be effective in improving patient satisfaction; however, concrete evidence remains insufficient. This study examined the association between the drug selection process and treatment satisfaction in amlodipine-treated patients, hypothesizing that shared selection process would increase patient satisfaction.
METHODS: Data from the 2024 Patient Mindscape survey were used. Patient Mindscape is a large-scale patient-reported outcome survey covering over 500,000 patients annually across 80 diseases nationwide in Japan. Subjects were patients diagnosed with hypertension who had been prescribed amlodipine besylate within the past year. The association between the drug selection process and treatment satisfaction was analyzed using Fisher's exact test.
RESULTS: Among 28,637 eligible patients, 98.7% (n = 28,278) were in the "Physician-prescribed" group, 0.5% (n = 139) in the "Physician presented multiple options and patient selected" group, and 0.8% (n = 220) in the "Patient-requested medication" group. The proportion reporting high treatment satisfaction (very satisfied/satisfied) was 67.1% in the "Physician-prescribed" group, 75.5% in the "Physician presented multiple options and patient selected" group, and 68.2% in the "Patient-requested medication" group. Treatment satisfaction in the "Physician presented multiple options and patient selected" group was statistically significantly higher than in the "Physician-prescribed" group (p = 0.037). No significant difference was found compared to the "Patient-requested medication" group.
CONCLUSIONS: A treatment drug selection process where physicians present multiple options and patients select is potentially associated with higher treatment satisfaction than physician-prescribed treatment. Enhanced communication between physicians and patients may contribute to improved satisfaction. Further analysis is warranted to elucidate additional factors that may influence patient satisfaction.

Conference/Value in Health Info

2025-11, ISPOR Europe 2025, Glasgow, Scotland

Value in Health, Volume 28, Issue S2

Code

PCR132

Topic

Health Service Delivery & Process of Care, Patient-Centered Research

Topic Subcategory

Patient Engagement, Patient-reported Outcomes & Quality of Life Outcomes

Disease

Cardiovascular Disorders (including MI, Stroke, Circulatory), No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×